Pharmaceutical

Gilead, CHAI and Penta to enhance HIV treatment for children

Gilead Sciences has entered into collaborations with CHAI and Penta ID network to expedite the development of dispersible HIV treatments.

Jul 15, 2023 - 20:00
Gilead, CHAI and Penta to enhance HIV treatment for children
Gilead Sciences has entered into collaborations with CHAI and Penta ID network to expedite the development of dispersible HIV treatments.
Read the original article

Tags:

Previous Article

Vistagen obtains Canadian Notice of Allowance for AV-101 patent

Next Article

Health Canada approves AstraZeneca-Merck’s prostate cancer therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: European Union drug pricing proposal for the pandemic treaty generates pushback

STAT+: European Union drug pricing proposal for the pan...

Apr 1, 2023

STAT+: 89bio treatment reduces liver scarring in patients with NASH, meeting study goals

STAT+: 89bio treatment reduces liver scarring in patien...

Mar 22, 2023

STAT+: Biogen’s boardroom scandal saddles CEO with first crisis

STAT+: Biogen’s boardroom scandal saddles CEO with firs...

Jun 14, 2023